SLC6A1 and autoimmune hepatitis: Of the p-CRMP2T514 suppressors identified that were profiled for in vivo activity, NNC-711, a reported blocker of GABA uptake via inhibition of SLC6A1 (solute carrier family 6 member 1; (GAT1))79, attenuated AIH when tested independently, but showed no additive effect when tested in combination with lithium (Fig. 5c, d).